United Therapeutics shows strong revenue growth, driven by Tyvaso, and maintains high margins and low debt burden. Read why I ...
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.
Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...
LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
In a regulatory filing, the Mumbai-based drug maker said that in 2023 it had settled with three plaintiff groups referred as ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Opinion
Editorial Roundup: United States
Excerpts from recent editorials in the United States and abroad: ___ Feb. 20 The Washington Post says Musk's mass firings are backfiring President Donald Trump and Elon Musk have been rapidly firing ...
President Donald Trump reportedly issued a stringent warning to pharmaceutical companies, advising them to repatriate their ...